![Tandem Diabetes Says Death Of Patient Wasn't Due To Insulin Pump Malfunction]( "Tandem Diabetes Says Death Of Patient Wasn't Due To Insulin Pump Malfunction")
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares traded lower Friday after a report of the death of a patient using Tandem’s T:SLIM X2 insulin pump was added to the Food and Drug Administration’s Adverse Event report system. A Tandem spokesman said the company couldn’t comment in detail because of health privacy rules, but did say the cause of death “was not due to insulin delivery or pump malfunction.
